Thus, the efficacy of Scutellarin was partly abolished by interfering with VEGF‐triggered upregulation of caspase 3, caspase 7, and IL‐1β, which provided a new idea for the clinical therapeutics of HIE. The gene discussed is IL1B; the disease is perinatal asphyxia.